Oddity Tech Ltd. (NASDAQ: ODD) Earnings Preview and Strategic Expansion into Telehealth

Core Insights - Oddity Tech Ltd. is set to release its quarterly earnings on November 19, 2025, with an expected EPS of $0.35 and revenue of approximately $145.47 million [1][6] Company Developments - The launch of Methodiq, a telehealth platform for medical skincare, signifies Oddity's strategic entry into the medical-grade skincare market, competing with companies like Hims [2][6] - Methodiq offers 28 new products targeting skin conditions such as acne and eczema, with prices ranging from $29 to $59, making them accessible to a broad audience [2] - The development of Methodiq took four years and integrates investments in biotechnology and AI-based computational imaging, allowing for online diagnosis and personalized treatments [3] Financial Performance - Oddity has a price-to-earnings (P/E) ratio of 18.89, indicating the market's valuation of its earnings [4][6] - The price-to-sales ratio stands at 2.76, reflecting investor willingness to pay per dollar of sales [4] - The enterprise value to sales ratio is 1.92, showing the company's total valuation relative to its sales [4] - The company maintains a low debt-to-equity ratio of 0.065, indicating conservative debt use [5] - A current ratio of 6.32 suggests strong liquidity, ensuring the company can cover short-term liabilities [5] - An earnings yield of 5.29% demonstrates Oddity's ability to generate earnings from each dollar invested [5]